Latest News

ECTRIMS 2022 Conference

December 6, 2022 | Education, Event, Research

The 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) took place in Amsterdam from 26th to 28th October, and was attended by Dr. John. Mottershead online. The programme included Scientific Sessions, Hot Topics and […]


Multiple Sclerosis New Zealand Research Trust 2022 Webinar Series

August 24, 2022 | Education, Event, Research, Webinar

The New Zealand Multiple Sclerosis Research Trust have announced the details for their annual webinar series. Registration for their 1st webinar is now open, and can be booked via Event Bright: Celebrating NZ Multiple Sclerosis Researchers Tickets, Sat 03/09/2022 at […]


MS Research Update Live Webinar – 16 August 2022 – Recording now available

August 9, 2022 | Education, Event, Research

Recording now available: https://www.msakl.org.nz/our-resources/webinars/latest-research-update/


Calling all people with Secondary Progressive MS

July 26, 2022 | Life with MS, Progressive, Research

Multiple Sclerosis NZ is currently in the process of providing information to Pharmac regarding the high unmet need of those with Secondary Progressive MS. A new treatment, Siponimod (Mayzent), is currently under review and due to be assessed by PTAC […]


Preclinical data support remyelinating potential of ABX-002

May 24, 2022 | Research

ABX-002, an experimental treatment for multiple sclerosis (MS) being developed by Autobahn Therapeutics, promoted the restoration of the myelin sheath in preclinical models of the disease, new data show. The research, which specifically tested an analog of ABX-002 called LL-341070, will be presented […]